Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Vanderbilt-Ingram Cancer Center
EpiBiologics
Boehringer Ingelheim
Aktis Oncology, Inc.
ViroMissile, Inc.
M.D. Anderson Cancer Center
AstraZeneca
Pfizer
Tizona Therapeutics, Inc
ALX Oncology Inc.
Dana-Farber Cancer Institute
IDEAYA Biosciences
Adaptimmune
Immunolight, LLC
UNC Lineberger Comprehensive Cancer Center
SN BioScience
Oscotec Inc.
VLP Therapeutics
Boehringer Ingelheim
Instituto Nacional de Cancer, Brazil
Novartis
West China Hospital
M.D. Anderson Cancer Center
Pfizer
University of Chicago
National Institutes of Health Clinical Center (CC)
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Case Comprehensive Cancer Center
Sanford Health
EMD Serono
Sichuan Baili Pharmaceutical Co., Ltd.
MeiraGTx UK II Ltd
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
The University of Texas Health Science Center, Houston
University of Wisconsin, Madison
Memgen, Inc.
Genexine, Inc.
Exelixis
Bicara Therapeutics
MacroGenics
Incyte Corporation
American College of Radiology
Medical College of Wisconsin
Dana-Farber Cancer Institute
Providence Health & Services
Providence Health & Services